NAGE
#3402
Niagen Bioscience, Inc. - Common Stock
3.4 7 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.36%
Variación mensual
-0.29%
Variación en los últimos 6 meses
-30.32%
Cambio anual
-30.32%
Cierres anteriores
3.3 9
Open
3.4 7
Mínimo
3.4 7
High
3.4 7
Volumen
65
Financials
- Market Capitalization 276.37 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
31.8
Relación precio/flujo de caja
4.2
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3390 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.73 USD | -2.36% | -4.60% | +8.43% | +54.13% | 285.21 M USD | ||
| 3394 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.47 USD | +0.32% | +19.27% | +53.24% | -5.30% | 282.09 M USD | ||
| 3413 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.57 USD | -6.21% | -9.59% | -23.96% | +73.71% | 272.57 M USD | ||
| 3429 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.97 USD | -7.51% | -10.45% | +23.90% | +328.26% | 265.09 M USD |